|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
|
BACK TO LIST |
European Patient Summary
|
|
|
|||||||||||||||||||
Problem list
| Condition | Onset Date | Status |
|---|---|---|
| Chronic kidney disease stage 2 | 2017-04-26 | active |
| Microalbuminuria due to type 2 diabetes mellitus | 2017-04-26 | active |
| Ischemic heart disease | 2015-10-14 | active |
| Disorder of kidney due to diabetes mellitus | 2010-05-12 | active |
| Chronic kidney disease stage 1 | 2010-05-12 | active |
| Alzheimer's disease | 2009-03-11 | active |
| Metabolic syndrome X | 2002-01-30 | active |
| Essential hypertension | 2000-01-19 | active |
| Impacted molars | 1990-06-30 | active |
| Prediabetes | 1980-11-26 | active |
| Anemia | 1980-11-26 | active |
| Recurrent urinary tract infection | 1957-08-29 | active |
Medication list
| Medication | Since | Form | Dosage | Reason |
|---|---|---|---|---|
| insulin isophane human 70 UNT/ML / insulin regular human 30 UNT/ML Injectable Suspension [Humulin] | 2025-07-23 | 10 units subcutaneously twice daily before breakfast and dinner | Prediabetes | |
| Amlodipine (as amlodipine besylate) 2.5 mg oral tablet | 2025-07-23 | Oral tablet | 1 tablet (2.5 mg) by mouth once daily | Essential hypertension (disorder) |
| Hydrochlorothiazide 25 mg oral tablet | 2025-07-23 | Oral tablet | 1 tablet (25 mg) by mouth once daily | Essential hypertension (disorder) |
| Lisinopril 10 mg oral tablet | 2025-07-23 | Oral tablet | 1 tablet (10 mg) by mouth once daily | Essential hypertension (disorder) |
| Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet | 2015-10-21 | Oral tablet | 1 tablet (75 mg) by mouth once daily | |
| Simvastatin 20 mg oral tablet | 2015-10-21 | Oral tablet | 1 tablet (20 mg) by mouth once daily | |
| Nitroglycerin 400 microgram/actuation sublingual spray | 2015-10-21 | Sublingual spray | 400 micrograms per spray, use one spray under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes | |
| Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet | 2015-10-21 | Prolonged-release oral tablet | 1 tablet (100 mg) once daily | |
| Galantamine (as galantamine hydrobromide) 4 mg oral tablet | 2009-03-11 | Oral tablet | 1 tablet (4 mg) once daily | Alzheimer's disease (disorder) |
| Vitamin B12 5 MG/ML Injectable Solution | 1980-12-03 | 1 mg (1 mL) intramuscularly once monthly |
Allergies and Intolerances
| No known allergies or intolerances |
Procedure History list
| Procedure | Date | Reason |
|---|---|---|
| Depression screening | 2025-04-23 | - |
| Assessment of health and social care needs | 2025-04-23 | - |
| Assessment using Morse Fall Scale | 2025-04-23 | - |
| Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) | 2025-04-23 | - |
| Screening for domestic abuse | 2025-04-23 | - |
| Assessment of substance use | 2025-04-23 | - |
| 2025-04-23 | - | |
| Medication reconciliation | 2025-02-19 | - |
| Assessment of anxiety | 2025-02-19 | - |
| Screening for drug abuse | 2025-02-19 | - |
| Depression screening using PHQ-9 (Patient Health Questionnaire 9) score | 2024-01-24 | - |
| Patient discharge | 2023-12-16 | - |
| Hospice care | 2023-12-15 | - |
| Notifications | 2023-12-06 | - |
| Certification procedure | 2023-12-06 | - |
| Initial patient assessment | 2023-12-06 | - |
| Development of individualized plan of care | 2023-12-06 | - |
| Pelvis X-ray | 2022-12-14 | - |
| Admission to orthopedic department | 2022-12-14 | Closed fracture of hip |
| Bone density scan | 2022-12-14 | Closed fracture of hip |
Immunizations list
| Vaccine | Date |
|---|---|
| Influenza virus antigen only vaccine product | 2025-05-21 |
| SARS-CoV-2 mRNA vaccine | 2021-03-10 |
| Clostridium tetani toxoid antigen adsorbed only vaccine product | 2019-11-20 |
Care Plan
| Immunization Recommendation | Due Date | Reason |
|---|---|---|
| Vaccine product containing only Influenza virus antigen (medicinal product) | 2025-10-01 | Annual seasonal influenza vaccination |
History of Past Illness
| Condition | Period | Status |
|---|---|---|
| Fracture of bone | 2022-12-14 – 2023-03-16 | inactive |
| Closed fracture of hip | 2022-12-14 – 2023-03-16 | inactive |
| Viral sinusitis | 2020-07-08 – 2020-07-26 | inactive |
| Viral sinusitis | 2017-09-20 – 2017-10-07 | inactive |
Vital Signs
| Vital Signs | 2025-07-23 | 2025-06-11 |
|---|---|---|
| Body Height | 159.2 cm | 159.2 cm |
| Pain severity - 0-10 verbal numeric rating [Score] - Reported | 0 {score} | 1 {score} |
| Body Weight | 69.2 kg | 69.2 kg |
| Body mass index (BMI) [Ratio] | 27.3 kg/m2 | 27.3 kg/m2 |
| Diastolic Blood Pressure | 63 mm[Hg] | 70 mm[Hg] |
| Systolic Blood Pressure | 97 mm[Hg] | 98 mm[Hg] |
| Heart rate | 84 /min | 96 /min |
| Respiratory rate | 15 /min | 13 /min |